Bristol Myers Squibb Company
430 E. 29th St
14th Floor
New York
New York
10016
United States
Tel: +1-800-332-2056
Website: http://www.bms.com/
About Bristol Myers Squibb Company
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
At Bristol Myers Squibb, we believe in the power of science to address some of the most challenging diseases of our time. Our focus on these unmet needs comes during a remarkable time, when unprecedented scientific breakthroughs are advancing the treatment of disease as never before in human history.
We work every day to transform patients’ lives through science. Each day, our employees around the world work together for patients – they are at the center of everything we do. They inspire us. They are the reason we come to work each day.
We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
Possibility Lives at BMS!
2899 articles about Bristol Myers Squibb Company
-
Bristol-Myers Squibb Company Touts Encouraging Update on Nivolumab in Lung Cancer
10/29/2013
-
Bristol-Myers Squibb Company Touts Promising Phase 2b Data on Rheumatoid Arthritis Clazakizumab
10/25/2013
-
Bristol-Myers Squibb Company Prices $1.5 Billion of Senior Notes
10/25/2013
-
Ex-Bristol-Myers Squibb Company Executive Gets One Year in Prison for Insider Trading
10/24/2013
-
Bristol-Myers Squibb Company's Profit Tops Estimates on Sales Growth
10/23/2013
-
Bristol-Myers Squibb Company to Present Data on Rheumatoid Arthritis Assets at American College of Rheumatology 2013 Annual Meeting
10/23/2013
-
Bristol-Myers Squibb Company Reports Third Quarter 2013 Financial Results
10/23/2013
-
Bristol-Myers Squibb Company Researcher Falsified Data in Grants and PhD Thesis
10/22/2013
-
Bristol-Myers Squibb Company Starts Hiring for Tampa Office
10/9/2013
-
Bristol-Myers Squibb Company Presentation and Poster to Highlight SQI Diagnostics’s Technology
10/8/2013
-
Former Bristol-Myers Squibb Company Chemist Sentenced to Life for Murdering Hubby
10/1/2013
-
Bristol-Myers Squibb Company to Announce Results for Third Quarter 2013 on October 23
10/1/2013
-
Bristol-Myers Squibb Company's Melanoma Drug Yervoy® Extends Patients' Lives by Up to 10 Years
9/30/2013
-
AstraZeneca PLC, Bristol-Myers Squibb Company Report Positive New Phase 3 Dapagliflozin Data
9/25/2013
-
AstraZeneca PLC, Bristol-Myers Squibb Company Recall Bydureon Diabetes Drug for Under-Filled Vials
9/20/2013
-
Université de Montréal's Institute for Research in Immunology and Cancer and IRICoR Achieve Important Milestone in Their Collaboration With Bristol-Myers Squibb Company
9/18/2013
-
Bristol-Myers Squibb Company Announces Dividend September 18, 2013
9/18/2013
-
PeptiDream Announces License of PeptiDream's Peptide Discovery Platform System (PDPS) Technology to Bristol-Myers Squibb Company and Extension of the Macrocyclic Peptide Drug Discovery Alliance Between the Companies
9/17/2013
-
Bristol-Myers Squibb Company Prostate Cancer Treatment Falls Short in Phase 3 Trial
9/13/2013
-
Bristol-Myers Squibb Company Picks New Tampa Home to House 579 Workers, Aims for "Culture of Innovation" at New Site
9/6/2013